Screening for diabetes in indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease

Kevin G. Rowley, M. Daniel, K. O'Dea

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Aims: Screening for diabetes using glycated haemoglobin (HbA1c) offers potential advantages over fasting glucose or oral glucose tolerance testing. Current recommendations advise against the use of HbA1c for screening but test properties may vary systematically across populations, according to the diabetes prevalence and risk. We aimed to: (i) characterize the properties of test cut-offs of HbA1c for diagnosis of diabetes relative to a diagnosis based on a fasting plasma glucose concentration of 7.0 mmol/l for high-risk Indigenous populations; and (ii) examine test properties across a range of diabetes prevalence from 5 to 30%. Methods: Data were collected from Aboriginal and Torres Strait Islander communities in Australia and a Canadian First Nations community (diabetes prevalence 12-22%) in the course of diabetes diagnostic and risk factor screening programmes (n = 431). Screening test properties were analyzed for the range of HbA1c observed (3-12.9%). Results: In separate and pooled analyses, a HbA1c cut point of 7.0% proved the optimal limit for classifying diabetes, with summary analysis results of sensitivity = 73 (56-86)%, specificity = 98 (96-99)%, overall agreement (Youden's index) = 0.71, and positive predictive value (for an overall prevalence of 18%) = 88%. For diabetes prevalence from 5 to 30% the post-test likelihood of having diabetes given HbA1c = 7.0% (positive predictive value) ranged from 62.7 to 93.2%; for HbA1c < 7.0%, the post-test likelihood of having diabetes ranged from 4.5 to 27.7%. Conclusions: The results converge with research on the likelihood of diabetes complications in supporting a HbA1c cut-off of 7.0% in screening for diabetes in epidemiological research. Glycated haemoglobin has potential utility in screening for diabetes in high-risk populations.

Original languageEnglish
Pages (from-to)833-839
Number of pages7
JournalDiabetic Medicine
Volume22
Issue number7
DOIs
Publication statusPublished - Jul 2005
Externally publishedYes

Fingerprint

Glycosylated Hemoglobin A
Population Groups
Sensitivity and Specificity
Fasting
Glucose
Diabetes Complications
Glucose Tolerance Test
Research
Population

Cite this

@article{c2b23c4d1ce04e54a7ab259f1c8009f6,
title = "Screening for diabetes in indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease",
abstract = "Aims: Screening for diabetes using glycated haemoglobin (HbA1c) offers potential advantages over fasting glucose or oral glucose tolerance testing. Current recommendations advise against the use of HbA1c for screening but test properties may vary systematically across populations, according to the diabetes prevalence and risk. We aimed to: (i) characterize the properties of test cut-offs of HbA1c for diagnosis of diabetes relative to a diagnosis based on a fasting plasma glucose concentration of 7.0 mmol/l for high-risk Indigenous populations; and (ii) examine test properties across a range of diabetes prevalence from 5 to 30{\%}. Methods: Data were collected from Aboriginal and Torres Strait Islander communities in Australia and a Canadian First Nations community (diabetes prevalence 12-22{\%}) in the course of diabetes diagnostic and risk factor screening programmes (n = 431). Screening test properties were analyzed for the range of HbA1c observed (3-12.9{\%}). Results: In separate and pooled analyses, a HbA1c cut point of 7.0{\%} proved the optimal limit for classifying diabetes, with summary analysis results of sensitivity = 73 (56-86){\%}, specificity = 98 (96-99){\%}, overall agreement (Youden's index) = 0.71, and positive predictive value (for an overall prevalence of 18{\%}) = 88{\%}. For diabetes prevalence from 5 to 30{\%} the post-test likelihood of having diabetes given HbA1c = 7.0{\%} (positive predictive value) ranged from 62.7 to 93.2{\%}; for HbA1c < 7.0{\%}, the post-test likelihood of having diabetes ranged from 4.5 to 27.7{\%}. Conclusions: The results converge with research on the likelihood of diabetes complications in supporting a HbA1c cut-off of 7.0{\%} in screening for diabetes in epidemiological research. Glycated haemoglobin has potential utility in screening for diabetes in high-risk populations.",
keywords = "Diabetes mellitus, Diagnosis, Glycated haemoglobin, Indigenous populations, Screening",
author = "Rowley, {Kevin G.} and M. Daniel and K. O'Dea",
year = "2005",
month = "7",
doi = "10.1111/j.1464-5491.2005.01447.x",
language = "English",
volume = "22",
pages = "833--839",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "7",

}

Screening for diabetes in indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease. / Rowley, Kevin G.; Daniel, M.; O'Dea, K.

In: Diabetic Medicine, Vol. 22, No. 7, 07.2005, p. 833-839.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Screening for diabetes in indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease

AU - Rowley, Kevin G.

AU - Daniel, M.

AU - O'Dea, K.

PY - 2005/7

Y1 - 2005/7

N2 - Aims: Screening for diabetes using glycated haemoglobin (HbA1c) offers potential advantages over fasting glucose or oral glucose tolerance testing. Current recommendations advise against the use of HbA1c for screening but test properties may vary systematically across populations, according to the diabetes prevalence and risk. We aimed to: (i) characterize the properties of test cut-offs of HbA1c for diagnosis of diabetes relative to a diagnosis based on a fasting plasma glucose concentration of 7.0 mmol/l for high-risk Indigenous populations; and (ii) examine test properties across a range of diabetes prevalence from 5 to 30%. Methods: Data were collected from Aboriginal and Torres Strait Islander communities in Australia and a Canadian First Nations community (diabetes prevalence 12-22%) in the course of diabetes diagnostic and risk factor screening programmes (n = 431). Screening test properties were analyzed for the range of HbA1c observed (3-12.9%). Results: In separate and pooled analyses, a HbA1c cut point of 7.0% proved the optimal limit for classifying diabetes, with summary analysis results of sensitivity = 73 (56-86)%, specificity = 98 (96-99)%, overall agreement (Youden's index) = 0.71, and positive predictive value (for an overall prevalence of 18%) = 88%. For diabetes prevalence from 5 to 30% the post-test likelihood of having diabetes given HbA1c = 7.0% (positive predictive value) ranged from 62.7 to 93.2%; for HbA1c < 7.0%, the post-test likelihood of having diabetes ranged from 4.5 to 27.7%. Conclusions: The results converge with research on the likelihood of diabetes complications in supporting a HbA1c cut-off of 7.0% in screening for diabetes in epidemiological research. Glycated haemoglobin has potential utility in screening for diabetes in high-risk populations.

AB - Aims: Screening for diabetes using glycated haemoglobin (HbA1c) offers potential advantages over fasting glucose or oral glucose tolerance testing. Current recommendations advise against the use of HbA1c for screening but test properties may vary systematically across populations, according to the diabetes prevalence and risk. We aimed to: (i) characterize the properties of test cut-offs of HbA1c for diagnosis of diabetes relative to a diagnosis based on a fasting plasma glucose concentration of 7.0 mmol/l for high-risk Indigenous populations; and (ii) examine test properties across a range of diabetes prevalence from 5 to 30%. Methods: Data were collected from Aboriginal and Torres Strait Islander communities in Australia and a Canadian First Nations community (diabetes prevalence 12-22%) in the course of diabetes diagnostic and risk factor screening programmes (n = 431). Screening test properties were analyzed for the range of HbA1c observed (3-12.9%). Results: In separate and pooled analyses, a HbA1c cut point of 7.0% proved the optimal limit for classifying diabetes, with summary analysis results of sensitivity = 73 (56-86)%, specificity = 98 (96-99)%, overall agreement (Youden's index) = 0.71, and positive predictive value (for an overall prevalence of 18%) = 88%. For diabetes prevalence from 5 to 30% the post-test likelihood of having diabetes given HbA1c = 7.0% (positive predictive value) ranged from 62.7 to 93.2%; for HbA1c < 7.0%, the post-test likelihood of having diabetes ranged from 4.5 to 27.7%. Conclusions: The results converge with research on the likelihood of diabetes complications in supporting a HbA1c cut-off of 7.0% in screening for diabetes in epidemiological research. Glycated haemoglobin has potential utility in screening for diabetes in high-risk populations.

KW - Diabetes mellitus

KW - Diagnosis

KW - Glycated haemoglobin

KW - Indigenous populations

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=21744437893&partnerID=8YFLogxK

U2 - 10.1111/j.1464-5491.2005.01447.x

DO - 10.1111/j.1464-5491.2005.01447.x

M3 - Article

VL - 22

SP - 833

EP - 839

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 7

ER -